Viewing Study NCT00030667


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-01-19 @ 5:29 PM
Study NCT ID: NCT00030667
Status: COMPLETED
Last Update Posted: 2015-04-15
First Post: 2002-02-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module